Showing results (31-40 of 267) with videos related to
Sort By:
Pageof 27
Annals of Epidemiology|August 16, 2018
Relative impact characteristic curve: a graphical tool to visualize and quantify the clinical utility and population-level consequences of implementing markersMohsen Sadatsafavi, Paul Gustafson, Zafar Zafari, et al.Respiratory Medicine|May 5, 2018
The projected economic and health burden of sub-optimal asthma control in CanadaZafar Zafari, Mohsen Sadatsafavi, Wenjia Chen, et al.The Lancet. Respiratory Medicine|July 26, 2015
Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisWenjia Chen, Jamie Thomas, Mohsen Sadatsafavi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 18, 2008
Heteroscedastic regression analysis of factors affecting BMD monitoringMohsen Sadatsafavi, Alireza Moayyeri, Liqun Wang, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|September 25, 2007
A new approach for quantifying change and test precision in bone densitometryWilliam D Leslie, Alireza Moayyeri, Mohsen Sadatsafavi, et al.Chest|November 6, 2016
Has Asthma Medication Use Caught Up With the Evidence?: A 12-Year Population-Based Study of TrendsMohsen Sadatsafavi, Hamid Tavakoli, Larry Lynd, et al.BMC Medical Informatics and Decision Making|January 12, 2023
A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseasesAbdollah Safari, John Petkau, Mark J FitzGerald, et al.International Journal of Obesity (2005)|April 3, 2023
Fragility of statistically significant outcomes in randomized trials comparing bariatric surgeriesYung Lee, Yasith Samarasinghe, Lucy H Chen, et al.Pharmacoepidemiology and Drug Safety|July 6, 2010
A quantitative evaluation of the regulatory assessment of the benefits and risks of rofecoxib relative to naproxen: an application of the incremental net-benefit frameworkLarry D Lynd, Carlo A Marra, Mehdi Najafzadeh, et al.BMC Pulmonary Medicine|February 14, 2018
Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based studyHamid Tavakoli, J Mark FitzGerald, Larry D Lynd, et al.Pageof 27